Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Adjunctive gabapentin treatment of bipolar disorder

Vieta, E, Martinez-Arán, A, Nieto, E, Colom, F, Reinares, M, Benabarre, A, Gastó, C · 2000 · European Psychiatry

Abstract

Introduction: The aim of this study was to analyze the effectiveness of gabapentin administration to bipolar patients who had an incomplete response to other mood stabilizers. Subjects and methods: Twenty-two RDC bipolar 1 and II patients were assessed by means of the SADS and entered if they gave their consent to participate. All them had suffered from frequent relapses, subsyndromal features (mostly depressive) and incomplete response to other drugs. They all received open-label increasing doses of gabapentin until clinical response. The patients were assessed through the CGI-BP and a specific questionnaire at baseline and at 12 weeks of follow-up. Results: Six out of the 22 patients dropped out for various reasons (four because of relapse, one because of side effects and one more because of poor compliance). Eight of the 16 patients that completed the 12-week follow-up showed at least two stages of improvement in the CGI. Using the last observation-carried forward analysis, the improvement was statistically significant for the depression subscale, and apparently related to social functioning, irritability and anxiety. Only one patient dropped out because of intolerance (mild rash). The mean dose of gabapentin was 1,310 mg/day. Conclusion: Gabapentin may be a useful drug for the add-on treatment of bipolar patients with poor response to other mood stabilizers. Gabapentin may improve depressive residual symptoms such as irritability, social withdrawal or anxiety. These results should be confirmed in randomized clinical trials.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0924-9338(00)00514-9

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 2

  1. Pande, 1999, Combination treatment in bipolar disorder, Bipolar Disord, 1, 17
  2. Vieta, 1999, Anticonvulsants in psychiatry. Round table series n° 64, 3

Cited by

See all 46

Metadata

Authors
Vieta, E., Martinez-Arán, A., Nieto, E., Colom, F., Reinares, M., Benabarre, A., & Gastó, C.
Affiliations
Hospital Clínic de Barcelona (ES)
Corresponding author
Vieta, E
Venue
European Psychiatry
Published
2000-11
Volume
15
Issue
7
Pages
433-437
ISSN
  • 0924-9338 (ISSN-L)
  • 1778-3585
OpenAlex
W2057301133
Cited by
46
References
20
Citations by year
2024: 2 · 2023: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 2 · 2012: 4
FWCI
2.79
Type
journal article
Language
en
Open access
closed
Locations
  • European Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
Instituto de Salud Carlos III
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
gabapentin, bipolar disorder, adjunctive therapy, mood stabilizers, relapse, depressive symptoms, irritability, social functioning, anxiety
MeSH terms
Gabapentin, Acetates, Adult, Amines, Anticonvulsants, Bipolar Disorder, Cyclohexanecarboxylic Acids, Drug Therapy, Combination, Female, Follow-Up Studies, gamma-Aminobutyric Acid, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Treatment Outcome, Antimanic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adjunctive gabapentin treatment of bipolar disorder. https://app.cochat.ai/papers/10.1016/s0924-9338(00)00514-9
The paper
Vieta, E., Martinez-Arán, A., Nieto, E., Colom, F., Reinares, M., Benabarre, A., & Gastó, C. (2000). Adjunctive gabapentin treatment of bipolar disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(00)00514-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.